Click for next page ( 122


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 121
GBiographies of Members of the Lucille P. Markey Charitable Trust Programs in Biomedical Sciences Committee Enriqueta Bond, Ph.D., is the president of the Burroughs Wellcome Fund and a former executive director of the Institute of Medicine. She is also a member of the IOM. Her research interests include genetics, mo- lecular biology, and science policy. She has served on the IOM's Board on Health Sciences Policy and on the Committee to Study Incentives for Resource Sharing in the Biomedical Sciences. Dr. Bond holds a Ph.D. in biology. William T. Butler, M.D., is the chancellor of Baylor College of Medi- cine, where he is also a professor of internal medicine and of microbiol- ogy and immunology. He served as the College's president and chief executive officer from 1979 to 1996. Before joining the Baylor faculty in 1966 Dr. Butler served as the chief clinical associate in the Laboratory of Clinical Medicine at the National Institute of Allergy and Infectious Dis- eases at the NIH. He is on the boards of Browning-Ferris Industries, C. R. Bard, Inc., and Lyondell Petrochemical, where he is chairman of the board. Dr. Butler has done extensive research on the effects of corticosteroids and other drugs on the immune system and on the mechanism of rejec- tion of organ transplants. He has written numerous publications in the fields of immunology, infectious disease, and medical administration. He holds an M.D. from Western Reserve University and a B.A. from Oberlin College. Dr. Butler is a member of the Institute of Medicine. Elaine K. Gallin, Ph.D., is the program director for medical research at the Doris Duke Charitable Foundation. Dr. Gallin's research involves the characterization of ion transport mechanisms in macrophages, leuko- 121

OCR for page 121
122 APPENDIX G cyte-endothelial cell interactions, and the effects of ionizing radiation of leukocyte function and vascular integrity. She received her B.S. from Cornell University, her M.S. from Hunter College, and her Ph.D. from City University of New York. She has held positions at the Uniformed Services University, Georgetown University Medical School, was a con- gressional fellow on the Public Policy Committee, and is a member of the Physiology Study Section at the NIH. Mary-Lou Pardue, Ph.D., is the Boris Magasanik Professor of Biology at the Massachusetts Institute of Technology and a member of the Na- tional Academy of Sciences. As a geneticist and cell biologist she has studied eukaryotic chromosomes with emphasis on sequences involved in the structure and function of chromosomes as organelles. She served as president of both the Genetics Society of America and the American Soci- ety for Cell Biology and was chair of the Institute of Medicine Committee on Understanding of the Biology of Sex and Gender Differences. She received a Ph.D. from Yale University in 1970. Georgine Pion, Ph.D., is a research associate professor of psychology and human development and senior fellow at the Vanderbilt Institute for Public Policy Studies at Vanderbilt University. She received her Ph.D. in social-environmental psychology from Claremont Graduate School in 1980 and did postdoctoral research training in the Division of Methodol- ogy and Evaluation Research at Northwestern University. She has served on committees involved in the evaluation of research and health profes- sional training programs and gender differences in the career develop- ment of scientists for He National Research Council, the National Science Foundation, and the National Institute of Mental Health. Currently she directs an evaluation of the neuroscience peer-review process at the NIH, evaluating the outcomes of new instructional strategies in biomedical engineering education and assessing the outcomes of postdoctoral re- search training programs sponsored by the Burroughs Wellcome Fund and other foundations. She is an associate of the National Academy of . Sciences. Lee Sechrest, Ph.D., is a professor of psychology at the University of Arizona. His primary interest is in development and improvement of methods for research and data analysis, particularly for research in field settings. He is also involved in program evaluation. Substantive areas include health and mental health services, clinical psychology, and per- sonality. Additional areas of expertise include research methodology, measurement, program evaluation, quality assurance in service delivery, and quality of scientific information. He is involved in matters having to do with the development of psychology as a responsible, science-based profession. Before going to Arizona he held faculty positions in Pennsyl- vania State University, Northwestern University, Florida State Univer-

OCR for page 121
APPENDIX G 123 sity, and the University of Michigan. He received his Ph.D. from the Ohio State University. Dr. Sechrest has served on five National Research Coun- cil committees, including the Panel to Study Gender Differences in the Career Outcomes of Science and Engineering Ph.D.s. Lloyd Hollingsworth Smith, M.D., is a professor emeritus of medi- cine and a former associate dean of the School of Medicine at the Univer- sity of California, San Francisco. His areas of expertise include biochemis- try, endocrinology and metabolism, internal medicine, and medical genetics. His interests and capabilities also include medical center admin- istration, medical education, training of investigators, and medical re- search policy. Dr. Smith holds an M.D. from Harvard Medical School and a B.A. from Washington and Lee University. Dr. Smith is a past member of the Board of Overseers of Harvard University. He is a member of the Institute of Medicine. He has previously served on the Committee to Study Strategies to Strengthen the Scientific Excellence of the NIH Intra- mural Research Program. Virginia Weldon, M.D., is a retired senior vice-president for public policy with the Monsanto Company. 1h this position she identified public policy issues affecting the company and planned for and orchestrated Monsanto approach to these issues. Before joining Monsanto in 1989 Dr. Weldon was a professor of pediatrics and associate vice-chancellor for medical affairs at the Washington University School of Medicine. Dr. Weldon is on the Board of Directors of G. D. Searle and Company, NutraSweet Company, and the Monsanto Fund. She holds an M.D. from the University of Buffalo and an A.B. from Smith College. She is a mem- ber of the Institute of Medicine and serves on the Report Review Commit- tee of the National Research Council and Institute of Medicine. fames Wyngaarden, M.D., is a professor emeritus at Duke Univer- sity. At Duke Dr. Wyngaarden served as associate vice-chancellor for health affairs, chief of staff and physician in chief at Duke University Hospital, and Frederic M. Hanes Professor and chairman, Department of Medicine at the Duke University School of Medicine. From 1982 to 1989 Dr. Wyngaarden was director, U.S. National Institutes of Health, and from 1989 to 1990 was associate director for life sciences, White House Office of Science and Technology Policy. Dr. Wyngaarden holds an M.D. from the University of Michigan Medical School. He is a member of the National Academy of Sciences and the Institute of Medicine and is a former foreign secretary of the NAS and IOM.

OCR for page 121